HLA disparity, cell dose and age as risk factors for DFS in cord blood transplantation after non-myeloablative conditioning in 112 adults with haematological malignancies.: A French multicentre study of the SFGM-TC and Eurocord

被引：0
|
作者：
Rio, B. [1 ]
Blaise, D. [2 ]
Renaud, M. [3 ]
Uzunov, M.
Bourhis, J. H. [4 ]
Ceballos, P. [5 ]
Maury, S.
Bulabois, C. [6 ]
Fouillard, L.
Deconinck, E. [7 ]
Dhedin, N.
Sirvent, A. [8 ]
Michallet, M. [9 ]
Contentin, N. [10 ]
Huynh, A. [11 ]
Buzyn, A.
Francois, S. [12 ]
Tabrizi, R. [13 ]
Yakoub-Agha, I. [14 ]
Chevalier, P. [15 ]
De Revel, T. [16 ]
Lapusan, S. [1 ]
Garnier, F. [17 ]
Boudjedir, K.
Gluckman, E.
Rocha, V.
机构：
[1] Hop Hotel Dieu, Paris, France
[2] IPC, Marseille, France
[3] CHU, Poitiers, France
[4] IGR, Villejuif, France
[5] CHU Montpellier, Montpellier, France
[6] CHU Grenoble, F-38043 Grenoble, France
[7] CHU Besancon, F-25030 Besancon, France
[8] CHU, Nice, France
[9] CHU, Lyon, France
[10] FCLC, Rouen, France
[11] CHU, Toulouse, France
[12] CHU Angers, Angers, France
[13] CHU, Bordeaux, France
[14] CHU Lille, F-59037 Lille, France
[15] CHU Nantes, F-44035 Nantes 01, France
[16] HIA, Clamart, France
[17] Eurocord, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 7 条
  • [1] Cord blood transplantation after non myeloablative conditioning (Minneapolis protocol): Impact on transplant outcomes in 112 adults with hematologic malignancy. A french multicentric study of the French Society for marrow transplant and cellular therapy (SFGM-TC) and Eurocord
    Rio, B.
    Blaise, D.
    Renaud, M.
    Uzunov, M.
    Bourhis, J. H.
    Ceballos, P.
    Maury, S.
    Bulabdis, C. E.
    Fouillard, L.
    Deconinck, E.
    Dhedin, N.
    Sirvent, A.
    Michallet, M.
    Contentin, N.
    Huynh, A.
    Buzyn, A.
    Francois, S.
    Tabrizi, R.
    Yakoub-Agha, I.
    Chevalier, P.
    de Revel, T.
    Lapusan, S.
    Garnier, F.
    Boudjedir, K.
    Gluckman, Eliane
    Rocha, V.
    BLOOD, 2007, 110 (11) : 604A - 604A
  • [2] Impact of total nucleated (TNC) and CD34+cell dose on different outcomes after double unrelated cord blood transplantation in patients with haematological malignancies. An analysis on behalf of the SFGM-TC and Eurocord
    Michallet, M.
    Cunha, R.
    Michel, G.
    Socie, G.
    Mohty, M.
    Rio, B.
    Blaise, D.
    Sirvent, A.
    Bordigoni, P.
    Deconinck, E.
    Yakoub-Agha, I.
    Rossi, J. -F.
    Maillard, N.
    Tabrizi, R.
    Ruggeri, A.
    Sobh, M.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S12 - S12
  • [3] Encouraging results of unrelated cord blood transplantation after homogenous reduced-intensity conditioning in adults with hematological malignancy: impact of HLA disparities on outcomes. A French multicentre study on behalf of the SFGM-TC and Eurocord
    Rio, B.
    Furst, A.
    Renaud, M.
    Legrand, F.
    Tabrizi, R.
    Uzunov, M.
    Lapusan, S.
    Blaise, D.
    Deconinck, E.
    Bourhis, H.
    Fouillard, L.
    Bulabois, C.
    Ceballos, P.
    Maury, S.
    Chevalier, P.
    Mohty, M.
    Francois, S.
    Huynh, A.
    Michallet, M.
    Sirvent, A.
    Dhedin, N.
    Contentin, N.
    Buzyn, A.
    Guyotat, D.
    Fagot, T.
    Yakoub-Agha, I.
    Gluckman, E.
    Ionescu, I.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S3 - S3
  • [4] Epstein Barr virus-related complications after unrelated cord blood transplantation: Incidence, risk factors and outcomes: a Eurocord and SFGM-TC collaborative study
    Dumas, P. Y.
    Ruggeri, A.
    Robin, M.
    Bay, J. O.
    Michallet, M.
    Bertrand, Y.
    Socie, G.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S81 - S82
  • [5] Long-term follow-up of 92 hematopoietic stem cell transplantation patients after non-myeloablative conditioning regimens:: a study from the SFGM-TC Registry
    Michallet, M
    Lé, Q
    Bilger, K
    Garban, F
    Huyn, A
    Blaise, D
    Milpied, N
    Bordigoni, P
    Kuentz, M
    Sadoun, A
    Cahn, JY
    Socié, G
    Michallet, A
    Nicolini, F
    Vigouroux, C
    Pigneux, A
    Boiron, JM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S58 - S59
  • [6] INCIDENCE AND RISK FACTORS OF GRAFT FAILURE AFTER CORD BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS : A SFGM-TC RETROSPECTIVE MULTICENTER STUDY
    Danhardt, Laura
    Wiedemann, Arnaud
    Michel, Gerard
    Rialland, Fanny
    Bertrand, Yves
    Jubert, Charlotte
    Maertens, Johan
    Sirvant, Anne
    Bunchbinder, Nimrod
    Devalck, Christine
    Brichard, Benedicte
    Paillard, Catherine
    Plantaz, Dominique
    Gandemer, Virginie
    Bruno, Benedicte
    Abboud, Miguel
    Pagliuca, Simona
    Raus, Nicole
    Devillier, Raynier
    Dalle, Jean-Hugues
    Neven, Benedicte
    Pochon, Cecile
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 358 - 359
  • [7] Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Francaise De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord
    Michallet, Mauricette
    Cunha, Renato L. G.
    Michel, Gerard
    Socie, Gerard
    Mohty, Mohamad
    Rio, Bernard
    Blaise, Didier
    Sirvent, Anne
    Tabrizzi, Reza
    Bordigoni, Pierre
    Deconinck, Eric
    Yakoubagha, Ibrahim
    Rossi, Jean-Francois
    Maillard, Natacha
    Sobh, Mohamad
    Garnier, Federico
    Ruggeri, Annalisa
    Gluckman, Eliane
    Rocha, Vanderson
    BLOOD, 2010, 116 (21) : 163 - 164
1